Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors
Authors
Keywords
-
Journal
Nano Today
Volume 50, Issue -, Pages 101834
Publisher
Elsevier BV
Online
2023-03-26
DOI
10.1016/j.nantod.2023.101834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune-related adverse events in various organs caused by immune checkpoint inhibitors
- (2022) Naoko Okiyama et al. ALLERGOLOGY INTERNATIONAL
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ATP‐Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity
- (2021) Lele Sun et al. ADVANCED MATERIALS
- Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
- (2021) Jing Liu et al. Nature Communications
- Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment
- (2020) Kyung Hwan Kim et al. OncoImmunology
- Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions
- (2020) Xiangfei Han et al. Nature Nanotechnology
- Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
- (2020) Eli P. Darnell et al. Current Oncology Reports
- The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
- (2020) Xiao-Hui Jia et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- An ingestible self-orienting system for oral delivery of macromolecules
- (2019) Alex Abramson et al. SCIENCE
- Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis
- (2019) Omar Abdel-Rahman Immunotherapy
- Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
- (2019) Yonghyun Lee et al. NATURE MATERIALS
- Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
- (2019) Nicholas G. Lamson et al. Nature Biomedical Engineering
- Advances in oral peptide therapeutics
- (2019) Daniel J. Drucker NATURE REVIEWS DRUG DISCOVERY
- Materials for oral delivery of proteins and peptides
- (2019) Tyler D. Brown et al. Nature Reviews Materials
- Ionic liquids for oral insulin delivery
- (2018) Amrita Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
- (2018) Yu Chao et al. Nature Biomedical Engineering
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
- (2018) Xiangsheng Liu et al. ACS Nano
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Layered defense: how mucus and tight junctions seal the intestinal barrier
- (2017) Christopher T. Capaldo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Contractile forces at tricellular contacts modulate epithelial organization and monolayer integrity
- (2017) Julie Salomon et al. Nature Communications
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts
- (2016) Elena Moroz et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of chemotherapeutics and proteins for synergistic therapy
- (2016) Chaoliang He et al. ADVANCED DRUG DELIVERY REVIEWS
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- Nanotopography Facilitates in Vivo Transdermal Delivery of High Molecular Weight Therapeutics through an Integrin-Dependent Mechanism
- (2015) Laura Walsh et al. NANO LETTERS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
- (2014) John C Castle et al. BMC GENOMICS
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Regulation of intestinal epithelial permeability by tight junctions
- (2012) Takuya Suzuki CELLULAR AND MOLECULAR LIFE SCIENCES
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Validation of a Static Franz Diffusion Cell System for In Vitro Permeation Studies
- (2010) Shiow-Fern Ng et al. AAPS PHARMSCITECH
- Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
- (2010) C. Kapitza et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now